meta_pixel
Tapesearch Logo
Log in
WSJ Tech News Briefing

TNB Tech Minute: Trump Clamps Down on Investment in Chinese Tech Firms

WSJ Tech News Briefing

The Wall Street Journal

Tech News, News

4.31.7K Ratings

🗓️ 19 December 2025

⏱️ 3 minutes

🧾️ Download transcript

Summary

Plus: BioMarin Pharmaceutical to acquire biotech Amicus Therapeutics for about $4.8 billion. And high-speed trading firm Jump Trading is accused of contributing to the collapse of Terraform Labs. Julie Chang hosts. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0

As companies seek to close growing gaps in skills and talent,

0:04.0

Deloitte US CEO Jason Garzatus believes it's important for organizations to understand their baseline of skills.

0:10.0

There's so many organizations that can't ask and answer the fundamental questions about how much computer science or data management skills do I have or AI development skills in a given domain? By performing a skills

0:21.9

inventory, leaders can truly understand where their efforts should be focused. Being blind to

0:26.6

those gaps is the real miss. Visit Deloitte.com to learn how your enterprise can help successfully

0:31.8

cultivate talent. Here's your afternoon T&B Tech Minute for Friday, December 19th. I'm Julie Chang for the Wall Street Journal.

0:41.2

President Trump has signed into law new powers to screen and restrict U.S. investment into Chinese tech firms.

0:47.9

The new outbound investment provisions are part of the annual National Defense Authorization Act,

0:52.9

and cite entities in China and other nations

0:55.2

of concern that develop dual-use technologies with both commercial and military applications.

1:01.8

The legislation cements a 2023 Biden administration executive order to monitor and in some cases

1:07.6

block U.S. financing of Chinese work on emerging technologies, including

1:12.2

AI, quantum, and advanced semiconductors. A spokesperson for the Chinese embassy in Washington said the

1:18.3

legislation overstretches the concept of national security and would distort normal investment

1:23.3

flows between the two countries. Biomarin Pharmaceutical has struck a deal to buy biotech amicus therapeutics for about $4.8 billion

1:32.4

in cash.

1:33.8

Biomerin makes treatments for rare genetic diseases.

1:37.0

The acquisition will expand its portfolio in treatments, including for the Fabri Enzyme

1:41.3

Disease and a muscle disorder called Pompeii disease.

1:45.3

The deal is slated to close in the second quarter of 2026. And we exclusively report that the administrator for bankrupt

1:51.9

Terraform Labs has filed a $4 billion lawsuit against high-speed trading firm, Jump Trading,

1:57.9

alleging it unlawfully profited from and contributed to the downfall of the crypto firm.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from The Wall Street Journal, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Wall Street Journal and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.